SOCRA 2024 Annual Conference Program Book - Flipbook - Page 4
Comprehensive solutions for drug and
device development and commercialization
Insight-driven expertise to navigate complexities
Drawing on our 30+ year CRO heritage, formerly as part of Covance and
Labcorp Drug Development, we deliver agility at a global scale. Through
19,000+ team members worldwide, we enable exceptional experiences
in drug, device and diagnostic development and commercialization.
Personalized solutions to meet your needs in >90 countries
Serving pharmaceutical, biotechnology and medical device customers
worldwide, we collaborate with you through every step of your drug,
device, or diagnostic development and commercialization journey.
Clinical
Pharmacology
A comprehensive
suite of integrated
offerings.
As your partner of choice, we are
raising the bar of what a CRO
should be. We deliver experience
and insights with agility and
creativity to unlock the potential
of new treatments.
We dig deeper to help you make
a profound difference in the lives
of patients. Wherever they are.
Whoever they are.
5,850+
Clinical
Development
Phase I-IV
clinical full service,
FSP and hybrid
models. Device
and diagnostic
development.
THE AGILE CRO
Enabling
Services
Technology enabled
trial solutions.
Patient access
support.
trials in the last 5 years
~92K
clinical investigators
1.029M+
par ticipants
Trial support spanning
countries
Therapeutic Specializations
Cardiovascular & Metabolism
Cell, Gene & Advanced Therapies
Hepatology
Immunology & Inflammation
Infectious Disease & Vaccines
Nephrology
Neurology & Ophthalmology
Oncology
Rare Diseases & Pediatrics
Respiratory
100
~700 physicians and
1 ,50 0PhDs globally
Solutions across the clinical trial continuum
Phase II
Phase I
Phase IV
Phase I-III clinical trials and consulting, with expert global regulatory
consulting, comprehensive decentralized trial solutions, data-driven
site engagement and patient recruitment know-how, with deep medical
expertise to translate protocols into reality.
Phase Ib
Phase III
Patient
Access
Commercialization and post-approval
support for your product's success,
in-market adoption, and long-term
follow-up studies.
RWE
©2024 Fortrea Inc. All Rights Reserved.
IS_0054_Capabilities_0224
- 4 -
